Related references
Note: Only part of the references are listed.Ki67 and cyclin A as prognostic factors in early breast cancer.: What are the optimal cut-off values?
C. Ahlin et al.
HISTOPATHOLOGY (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor
Takashi Suzuki et al.
CANCER SCIENCE (2007)
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients
Stephen O. Ikuerowo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Breast cancer patients with p53 pro72 homozygous genotype have a poorer survival
J Tommiska et al.
CLINICAL CANCER RESEARCH (2005)
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients
O Kilpivaara et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
H Eerola et al.
BREAST CANCER RESEARCH (2005)
Detection of cyclin B1 expression in G1-phase cancer cell lines and cancer tissues by postsorting western blot analysis
ML Shen et al.
CANCER RESEARCH (2004)
The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer
T Yoshida et al.
ANNALS OF ONCOLOGY (2004)
Prognostic relevance of histological grade and its components in node-negative breast cancer patients
A Volpi et al.
MODERN PATHOLOGY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma
H Lassus et al.
GYNECOLOGIC ONCOLOGY (2004)
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer
P Rudolph et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
H Kühling et al.
JOURNAL OF PATHOLOGY (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma
S Takeno et al.
CANCER (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
MP Look et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer:: association with prognosis
ZE Winters et al.
EUROPEAN JOURNAL OF CANCER (2001)
Chromogenic in situ hybridization -: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples
M Tanner et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
K Syrjäkoski et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Familial breast cancer in southern Finland:: how prevalent are breast cancer families and can we trust the family history reported by patients?
H Eerola et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
